Editions:  Austria · Denmark · France · Germany · Italy · Norway · Spain · Sweden · Switzerland
Advertisement

Competition Authority applies for cinema injunction

Share this article

15:52 CET+01:00
The Swedish Competition Authority (Konkurrensverket) yesterday applied for an injunction to stop the cinema chain SF Bio's acquisition of its competitor Sandrew Metronome, claiming that the deal would be damaging to competition.

Getinge posts healthy Q4 growth

Health care provider Getinge posted a pre-tax profit of 574 million crowns for Q4 with sales rising by 19 per cent to 3.5 billion crowns.

Orders rose by 11.5 per cent during the quarter. Orders increased by 20 per cent in the Medical Systems business area to 1.23 billion crowns, with orders surging by over 53 per cent on the North American market.

Schibsted's bid stands

Norwegian Schibsted has no plans to withdraw its bid for Finnish Alma Media despite the offer by Bonnier and Proventus to acquire Alma Media's broadcast business.

Schibsted also says that it has made a profit of 200 million Norwegian kroner on the sale of Swiss newspaper 20 Minuten.

Oriflame's Russian factory mystery

When Swedish Oriflame went public last year the cosmetics firm said that it was starting to build a new factory just outside Moscow. In reality, the company did not even have planning permission to build a factory - this arrived first in December 2004

MD Sven Mattsson cannot explain why the company has promised a building start for several years although nothing has happened.

Sources: Dagens Nyheter, Svenska Dagbladet, Dagens Industri

Supplied by BECK TRANSLATIONS.

With an experienced team of in-house translators, Beck specialises in translating from Swedish into English in such areas as finance and economics, marketing and advertising, biotechnology, the environment, quality, and personnel & administration.

Get notified about breaking news on The Local

Share this article

Advertisement
Advertisement
Advertisement
Jobs
Click here to start your job search
Advertisement
Advertisement

Popular articles

Advertisement
Advertisement